A new biotechnology enterprise creating treatments that alter chemical functions in immune cells agreed to license its technology to a pharmaceutical company. . . . → Read More: Start-Up Licenses Immunotherapies in $880M Deal
|
|||||
|
       
  |
Two biotechnology companies are researching use of a non-viral gene therapy to deliver synthetic antibodies for treating Covid-19 infections. . . . → Read More: Biotechs Explore Cell Therapy for Covid-19 Antibodies 
Drug maker Sanofi and biotechnology company Translate Bio are creating a new vaccine to protect against the virus causing Covid-19 infections . . . → Read More: Sanofi, Biotech Partner on RNA Covid-19 Vaccine 
A coalition of business and academic labs is creating a process to quickly identify antibodies in blood samples that neutralize viruses like SARS-CoV-2. . . . → Read More: Consortium to Find Neutralizing Viral Antibodies 
A life science incubator company plans to fund eight start-up enterprises developing diagnostics, vaccines, or treatments for the Covid-19 pandemic. . . . → Read More: Venture Fund to Back Covid-19 Start-Ups 
A clinical trial is beginning soon that tests a current drug for rheumatoid arthritis as a treatment for severe pneumonia in patients with Covid-19 infections. . . . → Read More: Trial to Test Arthritis Drug for Covid-19 Pneumonia 
An academic lab and spin-off company are developing engineered white blood cells with added cancer-killing proteins to attack solid tumor cancers. . . . → Read More: Engineered Blood Cells Created for Cancer Therapies 
Two drug discovery companies are forming a joint venture to discover treatments for neurological conditions based on cannabinoid-like compounds. . . . → Read More: New Venture Formed to Discover Neuro Therapies 
World Health Organization is organizing an international clinical trial to test four treatments for the novel coronavirus, or Covid-19, pandemic. . . . → Read More: WHO Beginning Covid-19 Therapy Trial
The Food and Drug Administration outlined steps clinical trial teams should take if their studies face disruptions from the novel coronavirus, or Covid-19, pandemic. . . . → Read More: FDA Outlines Trial Disruption Steps Due to Covid-19 |
||||
|
Copyright © 2020 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
